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We have used directed differentiation of ES cells towards the mesendodermal lineage in combination with microarray analysis to identify a set of PKs that are induced upon differentiation from the pluripotent stage. From these kinases, we identified one previously uncharacterised kinase, Vlk (Vertebrate lonesome kinase) that is well conserved in vertebrates, but which has no homologues outside of the vertebrate lineage. Its kinase domain cannot be classified as a member of any of the previously defined kinase groups, families or sub-families. Although Vlk is specifically expressed in E-cadherin positive cells in early embryogenesis, later its expression is confined to E-cadherin negative mesenchyme. We show that Vlk is enriched in the Golgi apparatus and that targeted disruption leads to a disruption in lung development and a delayed ossification of endochondral bone. Vlk mutants also display neonatal lethality due to respiratory failure with a suckling defect arising from a cleft palate. Our results demonstrate that Vlk is a novel vertebrate specific protein kinase that is essential for mesenchymal function. The generation of specialised tissues during animal development requires the implementation of specific cell differentiation programmes, which are governed by key transcription factors.
Muscle differentiation is a classic paradigm in which the conserved Mef2 transcription factor has a major role. Genomic ChIP analyses in Drosophila show that Mef2 binds to hundreds of mef2-regulated genes that are expressed at different stages of the differentiation programme, but it is not known how Mef2 co-ordinates the expression of these diverse target genes. One aspect is that Mef2 protein is expressed many hours before many target genes, indicating that Mef2 activity must be regulated during muscle differentiation. We have uncovered one mechanism that can do this: a novel inhibitor of muscle differentiation, Him, can down-regulate Mef2 transcriptional activity during both embryonic and adult muscle development. We have also found that genes expressed earlier in the embryonic muscle differentiation programme require lower levels of Mef2 activity for their expression than genes expressed later. We will present findings that lead to a model in which the level of Mef2 activity increases during embryonic muscle differentiation and results in the sequential activation of target genes. We will also present an 
